Therapeutic Asset Ratings
6,371 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Obinutuzumab
Primary Mediastinal Large B-Cell Lymphoma
Acepodia Biotech, Inc.
P2
BB
(64)
PANITUMUMAB
Refractory Colorectal Cancer
Northwestern University
P2
BB
(64)
Pembrolizumab
Adult Solid Tumor
CatalYm GmbH
P2
BB
(64)
Pembrolizumab
Cervical Carcinoma
Mayo Clinic
P2
BB
(64)
Pembrolizumab
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Seda S. Tolu
P2
BB
(64)
Pembrolizumab
Hormone Receptor-Positive Breast Cancer
Aminex Therapeutics, Inc.
P2
BB
(64)
Pembrolizumab
Mycosis Fungoides And Variants
University of Michigan Rogel Cancer Center
P2
BB
(64)
Pembrolizumab
Oropharynx Cancer
Turnstone Biologics, Corp.
P2
BB
(64)
Pembrolizumab
Richter Transformation
Roswell Park Cancer Institute
P2
BB
(64)
Pembrolizumab
Urinary Bladder Cancer
Fred Hutchinson Cancer Center
P2
BB
(64)
Pembrolizumab
Stage IV Bladder Cancer AJCC v8
Fred Hutchinson Cancer Center
P2
BB
(64)
Pembrolizumab
Ureter Cancer
Fred Hutchinson Cancer Center
P2
BB
(64)
Pembrolizumab
Thyroid Cancer
Kineta Inc.
P2
BB
(64)
Ponsegromab
Nutritional Disorder
Pfizer
P2
BB
(64)
Sugemalimab
Refractory Malignant Neoplasm
Second Affiliated Hospital of Soochow University
P2
BB
(64)
Tafasitamab
High Grade B-Cell Lymphoma
Brown University
P2
BB
(64)
Tislelizumab
Follicular Lymphoma
The First Affiliated Hospital with Nanjing Medical University
P2
BB
(64)
TRASTUZUMAB
Antineoplastic Agents
Incepta Pharmaceuticals Ltd
P2
BB
(64)
TRASTUZUMAB
ERBB2 Gene Amplification
SWOG Cancer Research Network
P2
BB
(64)
TRASTUZUMAB
Leptomeningeal Disease
The First Affiliated Hospital with Nanjing Medical University
P2
BB
(64)
TRASTUZUMAB
Locally Advanced Rectal Cancer
Academic and Community Cancer Research United
P2
BB
(64)
TRASTUZUMAB
Rectal Cancer
Academic and Community Cancer Research United
P2
BB
(64)
TRASTUZUMAB
Urinary Bladder Cancer
Iambic Therapeutics, Inc
P2
BB
(64)
Zanidatamab
Breast Carcinoma
QuantumLeap Healthcare Collaborative
P2
BB
(64)
Zanidatamab
HER2 Low Breast Carcinoma
QuantumLeap Healthcare Collaborative
P2
BB
(64)
Showing 526 to 550 of 6,371 assets
Previous
Page 22 of 255
Next